Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 Receptors (Q34394916)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 1, 2010
edit
Language Label Description Also known as
English
Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 Receptors
scientific article published on September 1, 2010

    Statements

    Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors (English)
    Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 Receptors (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit